C reactive protein and alpha1-antitrypsin: Relationship between levels and gene variants

Translational Research

Volumn 157, Issue 6, 2011, Pages 332-338

  Ottaviani, Stefania ^a   Gorrini, Marina ^a   Scabini, Roberta ^a   Kadija, Zamir ^a   Paracchini, Elena ^a   Mariani, Francesca ^a   Ferrarotti, Ilaria ^a   Luisetti, Maurizio ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BLOOD LEVEL; DNA POLYMORPHISM; GENE; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 79956144622     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.12.014     Document Type: Article

References (30)

1. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med 1998;4:1241-3.
2. Barnes PJ, Chowdhury B, Kharitonov SA, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:6-14. (Pubitemid 43955238)
3. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-68.
4. Pinto-Plata VM, Müllerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006;61:23-8. (Pubitemid 43106973)
5. Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hensen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:250-5. (Pubitemid 46203128)
6. Presta M, Camozzi M, Salvatori G, Rusnati M. Role of soluble pattern recognition receptor PTX3 in vascular biology. J Cell Mol Med 2007;11:723-38. (Pubitemid 47313297)
7. Steel DM, Whitehead DS. The major acute phase reactants: C reactive protein, serum amyloid P component, and serum amyloid A protein. Immunol Today 1994;15:81-8. (Pubitemid 24049801)
8. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983;52:655-709. (Pubitemid 13030691)
9. American Thoracic Society/European Respiratory Society Statement. Standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900.
10. Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1 antitrypsin deficiency. Thorax 2004;59:164-9.
11. Ferrarotti I, Scabini R, Campo I, et al. Laboratory diagnosis of alpha1-antitrypsin deficiency. Trans Res 2007;150:267-74.
12. Prins J, van der Maijden BB, Kraaijenhagen RJ, Wielders JPM. Inherited chronic obstructive pulmonary disease: new selectivesequencing work up for α1-antitrypsin deficiency identifies 2 previously unidentified Null alleles. Clin Chem 2008;54:101-7. (Pubitemid 351182602)
13. Ferrarotti I, Gorrini M, Scabini R, et al. Secondary outputs of alpha1-antitrypsin deficiency targeted detection programme. Respir Med 2008;102:354-8. (Pubitemid 351187966)
14. Zorzetto M, Russi E, Senn O, et al. SERPINA1 gene variants in individuals from the general population with reduced a1-antitrypsin concentrations. Clin Chem 2008;54:1331-8.
15. Kathiresan S, Larson MG,Vasan RS, et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 2006;113:1415-23. (Pubitemid 43739438)
16. Rhodes B, Morris DL, Subrahmanyan L, et al. Fine-mapping the genetic basis of CRP regulation in African Americans: a Bayesian approach. Hum Genet 2008;123:633-42.
17. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-908.
18. Brunner EJ, Kivimäki M, Witte DR, et al. Inflammation, insulin resistance, and diabetes - Mendelian randomization using CRP haplotypes points upstream. PLoS Med 2008;5:e155.
19. Kovacs A, Green F, Hansson LO, et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 2005;178:193-8. (Pubitemid 39600833)
20. Szalai AJ, Wu J, Lange EM, et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med 2005;83:440-7. (Pubitemid 40922166)
21. McDade TW, Burshop J, Dohnal J. High-sensitivity enzyme immunoassay for C- reactive protein in dried blood spot. Clin Chem 2004;50:652-4. (Pubitemid 38297322)
22. Gorrini M, Ferrarotti I, Lupi A, et al. Validation of a rapid, simple method to measure α1-antitrypsin in human dried blood spot. Clin Chem 2006;52:899-901. (Pubitemid 43673276)
23. Miravitlles M, Herr C, Ferrarotti I, et al. Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres. Eur Respir J 2010;35:960-8.
24. Hersh CP, Dahl M, Ly NP, Berkey CS, Nordestgaard BG, Silverman EK. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 2004;59:843-9. (Pubitemid 39389623)
25. Soerheim IC, Bakke P, Guslvik A, et al. a1-antitrypsin proteiase inhibitor MZ heterozygosity is associated with airlflow obstruction in two large cohorts. Chest 2010;138:1125-32.
26. Dahl M, Tybjaerg-Hansen A, Lange P,Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002; 136:270-9. (Pubitemid 34150756)
27. Thun GA, Ferrarotti I, Imboden M, et al. SERPINA1 MS and MZ heterozygotes and lung function decline in the SAPALDIA cohort study. Thorax, submitted.
28. Dahl M, Hersh CP, Ly NP, Berkey CS, Silverman EK, Nordestgaard BG. The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J 2005;26:67-76. (Pubitemid 40945933)
29. Werling D, Sutter F, Arnold M, Kun G, Tooten PCJ, Gruys E. Characterisation of the acute phase response of heifers to prolonged low dose infusion of lipopolysaccharide. Res Vet Sci 1996;61:252-7. (Pubitemid 126497074)
30. Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ. Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci 2006;6B:1045-56. (Pubitemid 43083934)